Skip to content

R³ Rehab Pathway Versus Usual Care After Lumbar Radicular Surgery

An Evidence-based Rehabilitation Pathway for Patients Undergoing Surgery for Lumbar Radicular Pain to Promote Return to Work: a Cluster Randomized Trial Comparison With Usual Care.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07313566
Acronym
Enrollment
480
Registered
2026-01-02
Start date
2026-03-16
Completion date
2028-05-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Radiculopathy, Radicular Low Back Pain

Keywords

Lumbar radiculopathy, Return to work, Case manager, Cluster RCT, Rehabilitation, radicular pain

Brief summary

The R³ trial is a multicentre cluster randomized controlled trial evaluating an evidence-based, person-centred rehabilitation pathway for patients undergoing lumbar surgery for radicular pain. The pathway includes structured pre-, peri-, and postoperative rehabilitation, early postoperative mobilization, case management, early return-to-work (RTW) guidance, and patient empowerment. Clusters (hospitals) are randomized to implement the R³ pathway (intervention) or continue usual care (control). The primary aim is to determine whether the R³ pathway reduces time to return to work compared with usual care.

Interventions

OTHERR³ Rehabilitation Pathway

A structured evidence-based rehabilitation pathway, guided by a case manager, starting preoperatively to 1 year postoperatively, including prehabilitation, perioperative rehabilitation and postoperative rehabilitation, with emphasis on fear reduction by keeping activity restrictions minimal and relevant, eliminating bracing and on active guidance to work resumption.

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER
Federal Knowledge Centre (KCE)
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Cluster randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Radicular pain (for ≥ 6 weeks prior to screening), with a clear indication for lumbar spinal surgery ((micro)discectomy, decompression and/or fusion), in accordance with the KCE guidelines (when evidence-based multimodal management has not improved pain or function and radiological findings are consistent with clinical symptoms) * Employed (working or on sick leave for less than 1 year due to spinal pathology) * Age 18 - 65 years * Surgery is scheduled within a timeframe of five days to 2 months after the decision for surgery (4 months for fusion) * For lumbar fusion surgery, the fusion should be restricted to one or two levels * Able to provide written informed consent, implying that the participant is both physically and cognitively capable of understanding the study information and signing the consent form independently.

Exclusion criteria

Patients are not eligible for the trial in case of any of the following criteria: * Lumbar surgery performed for malignant disease, spinal fracture, infectious spinal disease * Insufficient knowledge of Dutch or French language to receive education in the recruiting center and to complete the questionnaires (consistent with the language spoken in the recruiting centre) * Immediate surgery via emergency admission that precludes prehabilitation * Revision fusion surgery * Non-residency in Belgium

Design outcomes

Primary

MeasureTime frameDescription
Time to Return To Work (RTW)Assessed from surgery to 15 months postoperativelyTime to return to work, defined as at least 50% of the contractional work time before surgery (with a sustainable return to work being defined as remaining actively working for three months following work resumption). Outcome type: Time-to-event (days) Range: 0 to 450 days Interpretation: Shorter time indicates a better outcome

Secondary

MeasureTime frameDescription
Disability3 months and 12 months postoperativelyDisability scores assessed by the Oswestry Disability Index (ODI) at 3 months and 1 year postoperatively (key-secondary) Scale range: 0-100 points Interpretation: Higher scores indicate greater disability (worse outcome)
Percentage of patients returned to work4 weeks, 3 months and 1 year postoperativelyPercentage of patients returned to work at 4 weeks, 3 months and 1 year postoperatively Scale range: 0-100% Interpretation: Higher percentages indicate a better outcome
Patient-centered functional status4 weeks, 3 months and 1 year postoperativelyPatient-centered functional status assessed by the Patient-Specific Functional Scale (PSFS) at 4 weeks, 3 months and 1 year postoperatively Scale range: 0-10 per activity (mean score calculated) Interpretation: Higher scores indicate better functional ability
Back pain4 weeks, 3 months and 1 year postoperativelyBack pain measured with the Numeric Rating Scale (NRS) at 4 weeks, 3 months and 1 year postoperatively Scale range: 0-10 0 = no pain 10 = worst imaginable pain Interpretation: Higher scores indicate more severe pain (worse outcome)
Leg pain4 weeks, 3 months and 1 year postoperativelyLeg pain measured with the Numeric Rating Scale (NRS) at 4 weeks, 3 months and 1 year postoperatively Scale range: 0-10 0 = no pain 10 = worst imaginable pain Interpretation: Higher scores indicate more severe pain (worse outcome)
Health-related quality of life4 weeks, 3 months and 1 year postoperativelyEuroQoL 5D (EQ5D-5L) for measuring health-related quality of life at 4 weeks, 3 months and 1 year postoperatively Index score range: From \<0 (health states worse than death) to 1.0 (full health) Interpretation: Higher scores indicate better health-related quality of life
Work productivity4 weeks, 3 months and 1 year postoperativelyWork productivity measured with the IMTA Productivity Cost Questionnaire (iPCQ) at 4 weeks, 3 months and 1 year postoperatively Scale: Multiple items assessing absenteeism and presenteeism Range: Item-specific (continuous variables expressed in days or hours) Interpretation: Higher productivity loss indicates a worse outcome
Analgesics use4 weeks, 3 months and 1 year postoperativelyAnalgesics use, quantified by the Medication Quantification Scale (MQS) at 4 weeks, 3 months and 1 year postoperatively Scale range: 0 to no predefined maximum (higher scores reflect greater medication burden) Interpretation: Higher scores indicate greater analgesic use (worse outcome)
Kinesiophobia4 weeks, 3 months and 1 year postoperativelyKinesiophobia measured by the Tampa Scale for Kinesiophobia (TSK) at 4 weeks, 3 months and 1 year postoperatively Scale range: 17-68 Interpretation: Higher scores indicate greater fear of movement (worse outcome)
Pain catastrophizing4 weeks, 3 months and 1 year postoperativelyPain catastrophizing measured by the Pain Catastrophizing Scale (PCS) at 4 weeks, 3 months and 1 year postoperatively Scale range: 0-52 Interpretation: Higher scores indicate greater pain catastrophizing (worse outcome)

Countries

Belgium

Contacts

CONTACTOlivier Nachtergaele, MD
olivier.nachtergaele@uzleuven.be+32 16 34 02 72

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026